Article
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Nature - 11 Jun 2015
Najm Fadi J, Madhavan Mayur, Zaremba Anita, Shick Elizabeth, Karl Robert T, Factor Daniel C, Miller Tyler E, Nevin Zachary S, Kantor Christopher, Sargent Alex, Quick Kevin L, Schlatzer Daniela M, Tang Hong, Papoian Ruben, Brimacombe Kyle R, Shen Min, Boxer Matthew B, Jadhav Ajit, Robinson Andrew P, Podojil Joseph R, Miller Stephen D, Miller Robert H, Tesar Paul J
Abstract excerpt
Multiple sclerosis involves an aberrant autoimmune response and progressive failure of remyelination in the central nervous system. Prevention of neural degeneration and subsequent disability requires remyelination through the generation of new oligodendrocytes, but current treatments exclusively target the immune system. Oligodendrocyte progenitor cells are stem cells in the central nervous system and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
